Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review

• Published in: Internal and emergency medicine 2024-03, Vol.19 (2), p.275-293
• Main Authors: Di Vincenzo, Federica, Del Gaudio, Angelo, Petito, Valentina, Lopetuso, Loris Riccardo, Scaldaferri, Franco
• Format: Article
• Language: English
• Subjects: Autoimmune Diseases; Cardiovascular diseases; Diabetes mellitus (insulin dependent); Digestive system; Disease; Dysbacteriosis; Ecosystem; Endotoxins; Enteric nervous system; Fatty liver; Gastrointestinal Microbiome - physiology; Gastrointestinal tract; GUT INFLAMMATION IN HUMAN HEALTH AND DISEASE; High fat diet; Homeostasis; Humans; Im - Review; Inflammation; Inflammatory bowel diseases; Internal Medicine; Intestinal Barrier Function; Intestinal microflora; Intestinal Mucosa - metabolism; Intestinal Mucosa - microbiology; Intestinal Mucosa - pathology; Intestine; Lipopolysaccharides; Liver diseases; Medicine; Medicine & Public Health; Microbiomes; Neurodegeneration; Non-alcoholic Fatty Liver Disease; Oxidative stress; Permeability; Therapeutic applications
• ISSN: 1828-0447; 1970-9366
• DOI: 10.1007/s11739-023-03374-w

The intestine is the largest interface between the internal body and the external environment. The intestinal barrier is a dynamic system influenced by the composition of the intestinal microbiome and the activity of intercellular connections, regulated by hormones, dietary components, inflammatory mediators, and the enteric nervous system (ENS). Over the years, it has become increasingly evident that maintaining a stable intestinal barrier is crucial to prevent various potentially harmful substances and pathogens from entering the internal environment. Disruption of the barrier is referred to as 'leaky gut' or leaky gut wall syndrome and seems to be characterized by the release of bacterial metabolites and endotoxins, such as lipopolysaccharide (LPS), into the circulation. This condition, mainly caused by bacterial infections, oxidative stress, high-fat diet, exposure to alcohol or chronic allergens, and dysbiosis, appear to be highly connected with the development and/or progression of several metabolic and autoimmune systemic diseases, including obesity, non-alcoholic fatty liver disease (NAFLD), neurodegeneration, cardiovascular disease, inflammatory bowel disease, and type 1 diabetes mellitus (T1D). In this review, starting from a description of the mechanisms that enable barrier homeostasis and analyzing the relationship between this complex ecosystem and various pathological conditions, we explore the role of the gut barrier in driving systemic inflammation, also shedding light on current and future therapeutic interventions.